176 related articles for article (PubMed ID: 8889450)
1. Screening for hepatocellular carcinoma.
Haydon GH; Hayes PC
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):856-60. PubMed ID: 8889450
[TBL] [Abstract][Full Text] [Related]
2. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
3. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
4. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
[TBL] [Abstract][Full Text] [Related]
5. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
6. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.
Toyoda H; Kumada T; Osaki Y; Oka H; Urano F; Kudo M; Matsunaga T
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1528-36. PubMed ID: 17162244
[TBL] [Abstract][Full Text] [Related]
7. [Molecular markers for early diagnosis of hepatocellular carcinoma].
Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
[No Abstract] [Full Text] [Related]
8. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
Hussain K; El-Serag HB
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
10. [Early diagnosis of hepatocellular carcinoma by serum AFP and PIVKA-II analysis].
Aoyagi Y; Yanagi M; Asakura H
Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2003-7. PubMed ID: 8586921
[No Abstract] [Full Text] [Related]
11. [Tumor markers for hepatocellular carcinoma].
Fujiyama S; Tanaka M; Maeda S; Ashihara H; Hirata R
Gan To Kagaku Ryoho; 2001 May; 28(5):723-32. PubMed ID: 11383225
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Takasaki K; Takenami K; Yamamoto M; Nakano M
Cancer; 2000 Feb; 88(3):544-9. PubMed ID: 10649245
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
Nakamura S; Nouso K; Sakaguchi K; Ito YM; Ohashi Y; Kobayashi Y; Toshikuni N; Tanaka H; Miyake Y; Matsumoto E; Shiratori Y
Am J Gastroenterol; 2006 Sep; 101(9):2038-43. PubMed ID: 16848811
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Yano Y; Yamashita F; Kuwaki K; Fukumori K; Kato O; Yamamoto H; Ando E; Tanaka M; Sata M
Liver Int; 2006 Sep; 26(7):789-95. PubMed ID: 16911460
[TBL] [Abstract][Full Text] [Related]
15. [Clinical signification and evaluation of PIVKA-II in hepatocellular carcinoma].
Matsushima A; Enomoto M; Yokoo Y; Arai M; Kobayashi T; Okuno F; Hirano Y; Sujita K; Eto S; Takagi T
Rinsho Byori; 1989 Jun; 37(6):683-6. PubMed ID: 2477568
[No Abstract] [Full Text] [Related]
16. Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers.
Iizuka N; Oka M; Sakaida I; Moribe T; Miura T; Kimura N; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Yamashita S; Okita K; Sakata K; Karino Y; Toyota J; Ando E; Ide T; Sata M; Tsunedomi R; Tsutsui M; Iida M; Tokuhisa Y; Sakamoto K; Tamesa T; Fujita Y; Hamamoto Y
Clin Chim Acta; 2011 Jan; 412(1-2):152-8. PubMed ID: 20883676
[TBL] [Abstract][Full Text] [Related]
17. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
Tang W; Miki K; Kokudo N; Sugawara Y; Imamura H; Minagawa M; Yuan LW; Ohnishi S; Makuuchi M
Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of hepatocellular carcinoma.
Gomaa AI; Khan SA; Leen EL; Waked I; Taylor-Robinson SD
World J Gastroenterol; 2009 Mar; 15(11):1301-14. PubMed ID: 19294759
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers of hepatocellular carcinoma].
Kubo S; Matsukawa M
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2203-6. PubMed ID: 15628773
[TBL] [Abstract][Full Text] [Related]
20. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
Kaido T; Takada Y; Uemoto S
Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
[No Abstract] [Full Text] [Related]
[Next] [New Search]
